Trials / Completed
CompletedNCT00279279
PREPARE - Primary Prevention Parameters Evaluation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 700 (planned)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test specific device programming in patients without a previous history of a life-threatening, abnormally fast heartbeat who are implanted with a Medtronic ICD (Implantable Cardioconverter Defibrillator) or ICD with CRT (Cardiac Resynchronozation Therapy) device. The information learned from this study could be used to guide physicians in future ICD or CRT device programming.
Conditions
- Tachycardia, Ventricular
- Implantable Cardioverter Defibrillator (ICD)
- Fibrillation, Ventricular
- Syncope
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implanted Device |
Timeline
- Start date
- 2003-10-01
- Completion
- 2006-05-01
- First posted
- 2006-01-19
- Last updated
- 2006-10-26
Locations
32 sites across 2 countries: United States, Puerto Rico
Source: ClinicalTrials.gov record NCT00279279. Inclusion in this directory is not an endorsement.